Communiqués 10x Genomics, Inc.

Actions

TXG

US88025U1097

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq 22:00:00 25/09/2026			Varia. 5j.	Varia. 1 janv.
85,71 ^USD	+1,90%		+11,89%	+425,51%

24/09	Une initiée de 10x Genomics a vendu des actions d’une valeur de 464 668 dollars, selon un récent dépôt auprès de la SEC	MT
21/09	10x Genomics, Inc. : Deutsche Bank Securities toujours neutre sur le dossier	ZM

Communiqués

31/08	10x Genomics Wins Patent Infringement Verdict against Parse Biosciences	AQ
06/08	10x Genomics: Q2 Earnings Snapshot	AQ
06/08	10x Genomics Reports Second Quarter 2026 Financial Results	PR
30/07	10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care	AQ
18/06	10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer	AQ
09/06	10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group	PR
08/05	10x Genomics : First Quarter 2026 Prepared Remarks	PU
07/05	10x Genomics: Q1 Earnings Snapshot	AQ
07/05	10x Genomics Reports First Quarter 2026 Financial Results	PR
29/04	10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference	PR
19/04	10x Genomics : Introduces Atera	PU
19/04	10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood	PR
25/03	Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs	AQ
17/03	PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas	PR
19/02	10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference	PR
13/02	10x Genomics : Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)	PU
12/02	10x Genomics: Q4 Earnings Snapshot	AQ
12/02	10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026	PR
04/02	PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology	PR
26/01	10x Genomics : BioTuring and 10x Genomics Announce Strategic Collaboration to Streamline Single Cell and Spatial Data Analysis	PU
22/01	10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026	PR
12/01	10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease	PR
12/01	10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling	PR
12/01	Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology	PR
12/01	10x Genomics : 44th Annual J.P. Morgan Healthcare Conference	PU